Chih-Ming Liang
Overview
Explore the profile of Chih-Ming Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsai Y, Tai W, Liang C, Wu C, Tsai M, Hu W, et al.
J Microbiol Immunol Infect
. 2024 Oct;
58(1):62-69.
PMID: 39393964
Background: The inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC) is a complex disease with multifactorial etiology. The intestinal dysbiosis have been investigated to play an...
2.
Liang C, Wang C, Hung Y, Cheng H, Yang C
Heliyon
. 2024 Aug;
10(14):e34706.
PMID: 39149025
Electrodialysis (ED) is an eco-friendly and feasible method to separate or recover ionic compounds by electric field attraction and configuration of ion exchange membranes. Strain sp. H-2 could biotransform 5-hydroxymethylfurfural...
3.
Sou F, Hsu C, Chiu Y, Wu C, Lu L, Kuo C, et al.
J Formos Med Assoc
. 2024 Apr;
124(3):246-252.
PMID: 38589275
Background: Statins may reduce the risk of recurrent gallstone disease by decreasing bile cholesterol saturation and pathogenicity. However, limited studies have investigated this issue. This study aimed to assess whether...
4.
Tai W, Wu I, Wang H, Huang P, Yao C, Wu C, et al.
J Microbiol Immunol Infect
. 2024 Mar;
57(4):601-608.
PMID: 38461114
Background: High-dose dual therapy (HDDT) using proton-pump inhibitors (PPI) and amoxicillin attracted attention for its simplicity and lower adverse event profile. Besides, vonoprazan is not available worldwide. This real-world study...
5.
Wang H, Huang P, Yang S, Wu M, Tai W, Chen C, et al.
Life (Basel)
. 2023 Sep;
13(9).
PMID: 37763266
Background: Gastroesophageal reflux disease (GERD) affects a significant proportion of individuals, with life stress being a contributing factor. This study aimed to investigate the correlation between psychosomatic evaluations, heart rate...
6.
Liu A, Tai W, Chiu S, Sou F, Yang S, Lu L, et al.
Infect Drug Resist
. 2023 Sep;
16:6167-6174.
PMID: 37724089
Background: Endoscopic Retrograde Cholangiopancreatography (ERCP), used for choledocholithiasis treatment, carries a risk of pyogenic liver abscess (PLA) due to communication between the biliary system and bowel contents. However, limited data...
7.
Tsai J, Shih T, Tsai T, Lee S, Liang C
Prev Med Rep
. 2023 May;
34:102242.
PMID: 37214163
Little is known about how governments transparently communicate about COVID-19. This study conducted a content analysis of 132 government COVID-19 websites to identify the salience of health messages (i.e., perceived...
8.
Tai W, Yang S, Yao C, Wu C, Liu A, Lee C, et al.
Infect Dis Ther
. 2023 May;
12(5):1415-1427.
PMID: 37133673
Introduction: High-dose dual therapy (HDDT) can attain acceptable eradication rates provided that the optimal doses, timing and treatment duration are applied. The existing evidence still shows inconsistent reports (< 90%)...
9.
Ma T, Tai W, Loke S, Yao C, Liang C, Chuah S
Drugs Aging
. 2023 Jan;
40(1):71-79.
PMID: 36602725
Background: Aging may affect the efficacy of Helicobacter pylori eradication. The aim of our study was to assess the efficacy and safety of 7-day non-bismuth concomitant quadruple therapy as a...
10.
Liang C, Chiu Y, Lu L, Wu C, Sou F, Chiu S, et al.
Life (Basel)
. 2022 Dec;
12(12).
PMID: 36556365
Background: Evidence supporting the feasibility of single-stage stone removal in patients with a moderate grade of acute cholangitis remains insufficient. The maximal size of a common bile-duct stone suitable for...